Tenax Therapeutics (TENX) Revenue (2011 - 2015)

Tenax Therapeutics (TENX) posted quarterly Revenue of $49286.0 for Q2 2015, down 72.86% on a QoQ basis from $181572.0 in Q2 2013.

Tenax Therapeutics (TENX) Revenue (2011 - 2015) Analysis & Trends

Tenax Therapeutics has reported Revenue for 5 years, with the latest figure at $49286.0 in Q2 2015.

Revenue for Q2 2015 came in at $49286.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2016 was $49286.0 (down 94.91% YoY), and the FY2015 annual result was $49286.0, changed N/A from the prior year.
Revenue retreated to $49286.0 in Q2 2015, from $181572.0 in the prior quarter.
Over five years, Revenue peaked at $514872.0 in Q4 2012 and troughed at $24873.0 in Q3 2011.
A 4-year average of $152266.0 and a median of $95487.0 in 2012 frame the typical range for Revenue.
The widest annual swing landed in 2012, when Revenue soared 993.94%; it then surged 50.0% in 2013.
A 4-year view of Revenue shows it stood at $95159.0 in 2011, then soared by 441.06% to $514872.0 in 2012, then plunged by 64.73% to $181572.0 in 2013, then tumbled by 72.86% to $49286.0 in 2015.
Per Business Quant data, the three most recent Revenue figures were $49286.0 in Q2 2015, $181572.0 in Q2 2013, and $222388.0 in Q1 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Revenue (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	3.33 Bn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	4.29 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	1.52 Bn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	145.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	1.71 Bn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	1.29 Bn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	425.49 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	674.14 Mn
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	1.06 Bn
10	Tenax Therapeutics	80.73 Mn	80.73 Mn	-	-

Download Data